Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 291 trials across Europe, recruiting first
A study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.
GreeceBenzydamine Hydrochloride Lozenges for Non-Streptococcal Pharyngotonsillitis in Children Aged 6 to 11 Years
ItalyA study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.
AustriaA study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.
PolandAnti‑PD1 Therapy with pembrolizumab and cemiplimab in first‑line advanced non‑small cell lung cancer patients with high PD‑L1 expression
FrancePhase II Study of Intravenous Tarlatamab for Patients with Asymptomatic Brain Metastases from Small Cell Lung Cancer
The NetherlandsPhase 2 Study of Rinatabart Sesutecan with Pegfilgrastim in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
BelgiumRandomized trial of bupropion hydrochloride for fatigue in patients with long COVID (post‑COVID syndrome)
GermanyA study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma
AustriaA study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors
FranceA study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status
FranceA study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer
FranceThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
